5.36
Inogen Inc stock is traded at $5.36, with a volume of 615.38K.
It is up +2.49% in the last 24 hours and down -3.25% over the past month.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
See More
Previous Close:
$5.23
Open:
$5.25
24h Volume:
615.38K
Relative Volume:
2.29
Market Cap:
$142.25M
Revenue:
$351.50M
Net Income/Loss:
$-24.90M
P/E Ratio:
-5.849
EPS:
-0.9164
Net Cash Flow:
$-10.24M
1W Performance:
+4.28%
1M Performance:
-3.25%
6M Performance:
-16.51%
1Y Performance:
-36.64%
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INGN
Inogen Inc
|
5.36 | 142.25M | 351.50M | -24.90M | -10.24M | -0.9164 |
|
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | B. Riley Securities | Buy |
| May-22-25 | Upgrade | Needham | Hold → Buy |
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Trading the Move, Not the Narrative: (INGN) Edition - Stock Traders Daily
Inogen stock trades as Nasdaq reaches a new high - AD HOC NEWS
Inogen Portable Oxygen Concentrator(s) Review 2026 - The National Council on Aging (NCOA)
Technical Reactions to INGN Trends in Macro Strategies - Stock Traders Daily
Andy Reding Joins Inogen as Chief Operating Officer - Medical Product Outsourcing
Inogen Inc (NASDAQ: INGN) Grants 1,500 Shares to Chief Accounting Officer Mary E Wright at $5.33 Each - Kalkine Media
Inogen (INGN) CEO adds 1,500 shares in preset plan - Stock Titan
Inogen (INGN) accounting chief adds 1,500 shares in stock purchase - Stock Titan
INGN Q2 2026 Earnings: Narrower-than-Expected Loss Delivers 10.88% EPS SurpriseRevenue Warning Signal - dars.gov.et
Inogen (INGN) Results Versus Estimates: The Bottom-Line Figure Beats Its Comparison in the Latest Reading; Share Response: The Share Price Sheds 1.96% in the Available RecordReturn On Equity - vinanet.vn
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - TradingView
Zacks Investment ResearchGlobes - Globes - Israel Business News
Inogen (INGN) Shares: Ends Higher by 2.05% at $5.71 in the Current Update; Price Setup: the Supplied Trading Band Runs From $5.42 to $6.00 in the Latest SessionDescending Triangle - vinanet.vn
Top 3 Health Care Stocks That Could Blast Off This Month - Sahm
CPAP Store USA Adds New Inogen Aurora CPAP Mask Line - Sleep Review
Inogen (INGN) Cuts Guidance Even As Profitability Climbs - Yahoo Finance
Dimensional Fund Advisors LP Reduces Position in Inogen, Inc $INGN - MarketBeat
Inogen Inc. Earnings Call Balances Growth and Caution - TipRanks
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67 - Moomoo
Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists - Yahoo Finance
Should Investors Buy Inogen as Low Valuation Meets Execution Risk? - Yahoo Finance
Inogen Launches First CPAP Mask Portfolio - respiratory-therapy.com
Inogen Launches Voxi 5 Stationary Oxygen Concentrator - respiratory-therapy.com
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut - TradingView
Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Inogen (INGN) Has a New Rating from B. Riley Securities - The Globe and Mail
Inogen Inc (6IO.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Q2 2026 Inogen, Inc. Earnings Call Transcript - GuruFocus
Inogen Q2 2026 slides: international growth offsets U.S. weakness By Investing.com - Investing.com South Africa
Inogen Inc Q2 2026: Revenue $95.08M, EPS $(0.14) — 10-Q Summary - TradingView
Inogen (NASDAQ: INGN) posts Q2 2026 revenue growth but stays unprofitable - Stock Titan
Inogen, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Inogen Inc (INGN) (Q2 2026) Earnings Call Highlights: Strong Int - GuruFocus
Inogen, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-08-06 - Seeking Alpha
Inogen Q2 Earnings Call Highlights - marketbeat.com
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Is Inogen Inc (INGN) Undervalued After Q2 Earnings Miss? EPS at -$0.15, Revenue at $95.1M, GF Score: 66/100 - GuruFocus
Inogen Inc earnings beat by $0.03, revenue topped estimates - Investing.com
Inogen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Inogen (NASDAQ:INGN) Falls as Revenue Misses and Full-Year Guidance Trails Estimates - ChartMill
Inogen, Inc. Revises Earnings Guidance for Full Year 2026 - marketscreener.com
Inogen: Q2 Earnings Snapshot - marketscreener.com
Inogen posts Q2 2026 revenue $95.1M, raises full-year adjusted EBITDA guidance to ~$4.0M - TradingView
Tranche Update on Inogen, Inc.'s Equity Buyback Plan announced on February 24, 2026. - marketscreener.com
Inogen Announces Second Quarter 2026 Financial Results - Business Wire
Earnings call transcript: Inogen cuts 2026 revenue view after Q2 beat - Investing.com
Inogen, Inc. expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Arrowstreet Capital Limited Partnership Acquires 393,310 Shares of Inogen, Inc $INGN - marketbeat.com
Responsive Playbooks and the INGN Inflection - Stock Traders Daily
Inogen (NASDAQ:INGN) Stock Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat
Inogen, Inc Revenue Breakdown – NASDAQ:INGN - tradingview.com
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):